On April 15, the U.S. Food and Drug Administration (FDA) approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Read more.
FDA approves Corlanor for treatment of heart failure
Share
On April 15, the U.S. Food and Drug Administration (FDA) approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Read more.